Product analysis
Blood Pressure Health may offer modest blood-pressure support from its grape-seed extract, although results are mixed and depend on the exact extract used. Hawthorn does not have an established additional benefit for routine heart health here.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality40
The grape and hawthorn components are identified, but their quality remains uncertain. Naming their plant compounds alone does not establish the quality of the preparations.
Ingredient Transparency100
Both ingredients have amounts and forms identified. That helps with comparisons, though similarity to a particular researched extract still needs to be established.
Value For Money75
The low serving cost is favorable in the hawthorn comparison. Value for the grape component remains uncertain.
Customer Satisfaction86
Customers generally rate the supplement positively, with a large review base. Those ratings do not establish a blood-pressure benefit.
Product Focus68
Blood-pressure support from grape seed remains uncertain because results are mixed and depend on matching the MegaNatural-BP extract. Hawthorn findings concern a different preparation and do not establish added routine heart support.
- Format
Capsule - Container
- 90 Capsule(s)
- Per serving
- $0.21
- Customer rating
- 4.6 · 6,614 ratings
Goals
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Grape seed extract (Polyphenols) | 150 mg | |
Hawthorn extract (Vitexin-2”-O-Rhamnoside) | 300 mg |
How this ingredient is rated
Composition and Label Disclosure57
Marker and Preparation Disclosure
Species Name Disclosure
Composition and Label Disclosure
Commercial Price and Usability100
Commercial Price per Labeled Serving
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Real world effectiveness of Hawthorn special extract WS 1442 in a retrospective cohort study from Germany.
- Hawthorn (Crataegus spp.) Clinically Significantly Reduces Blood Pressure in Hypertension: A Meta-Analysis of Randomized Placebo-Controlled Clinical Trials.
- A randomised double blind placebo controlled clinical trial of a standardised extract of fresh Crataegus berries (Crataegisan) in the treatment of patients with congestive heart failure NYHA II.
- [Crataegus Special Extract WS 1442. Assessment of objective effectiveness in patients with heart failure (NYHA II)].
- Prospective, comparative cohort studies and their contribution to the benefit assessments of therapeutic options: heart failure treatment with and without Hawthorn special extract WS 1442.
- [Actions of standardized extracts of Crataegus berries on exercise tolerance and quality of life in patients with congestive heart failure].
- Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials.
- Clinical efficacy of crataegus extract WS 1442 in congestive heart failure NYHA class II.
- Baseline severity but not gender modulates quantified Crataegus extract effects in early heart failure--a pooled analysis of clinical trials.